Singapore says no strokes linked to 200,000 Pfizer bivalent shots


SINGAPORE, Jan 21 (Bloomberg): Singapore has not received any reports of strokes among those who received Covid bivalent vaccines made by Pfizer Inc. and BioNTech SE, after US authorities said the shot could potentially be linked to the condition among those 65 and older.

The city-state has administered about 200,000 doses of Pfizer’s shot - designed to target both the original Covid strain and omicron subvariants - by the end of last year, the Health Sciences Authority said Friday in response to queries from Bloomberg News.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Singapore , Pfizer , No Issues

Next In Aseanplus News

Tesso Nilo national park in Riau welcomes new baby elephant
Cambodia inaugurates major China-funded highway to boost regional trade, tourism
Smartphone 'detox' a refresh for peace of mind
PJ MP ‘quit’ more than a year ago, says Anwar
Oil retreats as market weighs mixed supply signals
Malaysia still far from target of 3,000 smart factories by 2030
Positive progress made in BN-PAS talks, says Umno sec-gen
Farhan explains story behind viral Verstappen takraw photo
Good air quality recorded across all districts in Brunei
Troubled UMNO-linked firm Zetrix owes Malaysian government over RM200mil in collections: Source

Others Also Read